APR 21, 2019 10:20 PM PDT

Type 2 Diabetic Drug Reverses Heart Failure

WRITTEN BY: Nouran Amin

In a study published in the Journal of American Cardiology, a drug used for the treatment of diabetes—empagliflozin—was shown to improve the hearts function by reversing the progression of heart failure in non-diabetic animal models.

"This drug could be a promising treatment for heart failure in both non-diabetic and diabetic patients," said lead author Juan Badimon, MD, Professor of Cardiology and Director of the Atherothrombosis Research Unit at the Cardiovascular Institute at the Icahn School of Medicine at Mount Sinai. "Our research can lead to a potential application in humans, save lives, and improve quality of life."

Learn more about how diabetes is related to heart disease:

In diabetes, empagliflozin limits renal sugar resorption in individuals with Type 2 diabetes. Past studies have confirmed that these patients that take empagliflozin don't commonly develop heart failure despite having a higher risk due to their diabetes. These studies led researchers to wonder if the drug exerts action independent of anti-diabetic activity that is implicated in heart failure prevention.

Researchers found that the drug reversed heart failure by improving cardiac metabolism—producing more energy and function more strongly and efficiently.

"This study confirmed our hypothesis that empagliflozin is an incredibly effective treatment for heart failure and not only an antidiabetic drug. Moreover, this study demonstrated that empagliflozin is useful for heart failure independently of a patient's diabetic status. Importantly, empagliflozin switches cardiac metabolism toward fatty acid and ketone body consumption, thus allowing the production of more energy in the heart," explained co-lead author Carlos Santos-Gallego, MD, postdoctoral fellow at the Icahn School of Medicine at Mount Sinai. "Empagliflozin may be a potentially effective treatment for heart failure patients. This is extremely important because heart failure is a disease with a mortality above 50 percent at 5 years. This study offers a new therapeutic strategy in heart failure, something badly needed given that there have not been new effective drugs for heart failure since the 1990s."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 21, 2021
Cannabis Sciences
Cannabis as a Prospective Treatment for Fibromyalgia? - Emerging Evidence
OCT 21, 2021
Cannabis as a Prospective Treatment for Fibromyalgia? - Emerging Evidence
Fibromyalgia is a common disease impacting millions of adults in the United States. The condition can be extremely debil ...
OCT 26, 2021
Microbiology
A Strategy to Improve the Efficacy of Antibiotics
OCT 26, 2021
A Strategy to Improve the Efficacy of Antibiotics
For many years, scientists and experts have warned about a building crisis - antibiotics are becoming less reliable, bac ...
OCT 29, 2021
Health & Medicine
The Happenstance Discovery of Delta 10 THC
OCT 29, 2021
The Happenstance Discovery of Delta 10 THC
The random discovery of Delta 10 is a good example of how cannabis science has only just begun to explore the complexity ...
NOV 30, 2021
Drug Discovery & Development
Enabling new levels of quantification with the SCIEX 7500 system - powered by SCIEX OS Software
NOV 30, 2021
Enabling new levels of quantification with the SCIEX 7500 system - powered by SCIEX OS Software
Sensitivity is a fundamental performance characteristic of a mass spectrometer The SCIEX 7500 system is enabling new lev ...
NOV 24, 2021
Drug Discovery & Development
A prescription digital therapeutic to treat alcohol use disorders
NOV 24, 2021
A prescription digital therapeutic to treat alcohol use disorders
Can a software application be used treat alcohol use disorders? The medical technology company Pear Therapeutics is ...
DEC 07, 2021
Microbiology
Gut Microbes Could Help Protect Us From Viral Infection, Including COVID-19
DEC 07, 2021
Gut Microbes Could Help Protect Us From Viral Infection, Including COVID-19
The human microbiome is closely connected to our immune system. Our bodies have to be able to keep the bacterial populat ...
Loading Comments...